High-dose ursodeoxycholic acid as a therapy for patients with primary sclerosing cholangitis.
about
Diagnosis and Therapeutic Management of Extra-Intestinal Manifestations of Inflammatory Bowel DiseaseBile acids for primary sclerosing cholangitisBile acids for primary sclerosing cholangitisHigh-dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitisA review of the medical treatment of primary sclerosing cholangitis in the 21st centuryPrimary sclerosing cholangitis: diagnosis and treatmentOverlap syndromes: an emerging diagnostic and therapeutic challengePathogenesis of primary sclerosing cholangitis and advances in diagnosis and managementHigh-dose ursodeoxycholic acid is associated with the development of colorectal neoplasia in patients with ulcerative colitis and primary sclerosing cholangitisUrsodeoxycholic acid treatment of vanishing bile duct syndromes.The predictors of the presence of varices in patients with primary sclerosing cholangitisBile acid changes after high-dose ursodeoxycholic acid treatment in primary sclerosing cholangitis: Relation to disease progression.A pilot trial of high-dose ursodeoxycholic acid in nonalcoholic steatohepatitisTreatment of autoimmune liver disease: current and future therapeutic options.Primary sclerosing cholangitis: updates in diagnosis and therapyCurrent status of therapy in autoimmune liver diseaseExtraintestinal manifestations in inflammatory bowel disease.Recurrence of primary sclerosing cholangitis after liver transplantation.Investigational pharmacologic treatment for liver disease.Sclerosing pancreatitis presenting as a periampullary tumour.Review article: current management of primary sclerosing cholangitis.Colorectal Cancer in Inflammatory Bowel Disease: Epidemiology, Pathogenesis and SurveillancePrimary sclerosing cholangitis, autoimmune hepatitis and overlap syndromes in inflammatory bowel diseaseHigh-dose ursodeoxycholic acid increases risk of adverse outcomes in patients with early stage primary sclerosing cholangitis.Clinical features and management of primary sclerosing cholangitis.Treatment options for primary sclerosing cholangitis.Systematic review: management options for primary sclerosing cholangitis and its variant forms - IgG4-associated cholangitis and overlap with autoimmune hepatitis.Primary sclerosing cholangitis: is any treatment worthwhile?Review article: controversies in the management of primary biliary cirrhosis and primary sclerosing cholangitis.Surrogate endpoints for clinical trials in primary sclerosing cholangitis: Review and results from an International PSC Study Group consensus process.Emerging treatments for primary sclerosing cholangitis.Pharmacological interventions for primary sclerosing cholangitis: an attempted network meta-analysis.Leukocytapheresis Therapy Improved Cholestasis in a Patient Suffering from Primary Sclerosing Cholangitis with Ulcerative Colitis.High-dose ursodeoxycholic acid in the treatment of primary sclerosing cholangitis: throwing the urso out with the bathwater?Sclerosing cholangitis in critically ill patients: an important and easily ignored problem based on a German experience.Incomplete response to ursodeoxycholic acid in primary biliary cirrhosis: is a double dosage worthwhile?Harnois et al.: Study of high-dose ursodeoxycholic acid.Intestinal absorption and biliary secretion of ursodeoxycholic acid and its taurine conjugate.A prospective, randomized-controlled pilot study of ursodeoxycholic acid combined with mycophenolate mofetil in the treatment of primary sclerosing cholangitis.Metronidazole and ursodeoxycholic acid for primary sclerosing cholangitis: a randomized placebo-controlled trial.
P2860
Q22241416-66A1C71F-ABD8-4A9F-B0C4-E09093041E43Q24234678-5C8B5044-D579-416D-998D-FEA2CBBA7470Q24248730-2D02A9E7-6B04-4450-93EB-91CEAF1DDA76Q24655731-6C5A0C14-2FEA-4DF3-A127-ADC0E3C8C9ACQ26771816-D65A8E15-7D99-454C-91A1-239442464717Q26829216-E79F5FD1-7FA5-496D-A22E-27C41C6BCCFBQ26830851-FE7B87BA-F5E2-424D-B3BD-531F66308006Q27015831-2CBE0C66-85C6-403C-88DB-96C464A09252Q28237152-1BA6350D-F7DD-4363-A6DE-4435A0FC13ECQ33866782-4C9031E2-BC79-49AA-9599-E4347FD3CBB9Q33966445-F9E7F39A-9331-4B2C-B151-B3B781C46F00Q34083354-3BE018B9-E9DB-4BB8-9541-58F5A7C87528Q34130429-DCA44BA3-5C1E-4921-8C89-5C37BBBED406Q34342199-1368DDDF-A27D-4A99-AC7B-4CBD6303A534Q34382536-2429D8CA-57ED-44E9-A340-C2D016C60088Q34408950-CD7C14B5-C7DC-46EA-B30A-13401BD149A2Q34488386-782245BA-5177-4673-8942-F1A3718E3D0FQ34713191-36A09843-80D2-4762-9F29-8F1EB00EE1C6Q34841865-E794CD84-0518-497A-835E-4C10578271D3Q36063220-27D71527-3839-4CCC-869F-4A89D8243B48Q36090744-AEA2E4F4-2FAF-424C-A599-72CC2F8AA345Q36281579-BF8D2E5B-3990-4535-A5A7-0102AB1EA50BQ37058852-455B3354-9F11-486F-90F7-74BFD6A2FCDFQ37117971-0018BE75-C195-482E-9C5A-593C7E58B979Q37182946-BFCBB613-9122-4081-B63E-A986CFF732A0Q37777156-2341A543-DCED-48BC-A0A5-A882B9447733Q37866339-570AF141-9469-4CCE-BC23-3D781EDC45B0Q37962395-38D780AD-5F40-4BEA-B0D5-C4C88080D868Q38174167-C8F06C72-1C8B-42C6-951B-7E294FE9BA86Q38595151-578F435A-637C-4B94-9E09-3C79E24C139CQ38748384-2ABA195B-84F8-46D8-BF5E-3DF00FC6FE45Q38833243-E21FED88-D539-47F0-AB77-CB925B838299Q42739829-507D13E5-543C-43C9-B8C2-EFC9663F1B62Q43284332-47C09E08-8D7E-4EC4-9C7E-D5C51C4B8F71Q43585465-E5B68D75-9D6C-4A1B-A10C-1EE6740B217EQ43807982-193B7711-8A15-4270-AC89-80545F1CC7AEQ43865102-47EC6B7F-F813-42C7-AD9D-B19681A3B1ADQ44111064-A4D24CF2-2057-4FD0-929D-CB5C1BB29B63Q44906209-063BF66C-5564-48DB-B144-6D3DC4656684Q45163892-44A46888-4A1A-44B7-A019-24ABA9F1A364
P2860
High-dose ursodeoxycholic acid as a therapy for patients with primary sclerosing cholangitis.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
High-dose ursodeoxycholic acid ...... rimary sclerosing cholangitis.
@en
High-dose ursodeoxycholic acid ...... rimary sclerosing cholangitis.
@nl
type
label
High-dose ursodeoxycholic acid ...... rimary sclerosing cholangitis.
@en
High-dose ursodeoxycholic acid ...... rimary sclerosing cholangitis.
@nl
prefLabel
High-dose ursodeoxycholic acid ...... rimary sclerosing cholangitis.
@en
High-dose ursodeoxycholic acid ...... rimary sclerosing cholangitis.
@nl
P2093
P2860
P1476
High-dose ursodeoxycholic acid ...... rimary sclerosing cholangitis.
@en
P2093
Harnois DM
Jorgensen RA
Larusso NF
P2860
P304
P356
10.1111/J.1572-0241.2001.03777.X
P407
P577
2001-05-01T00:00:00Z